Delivery details + Order by fax
  • PDF: Delivered by email usually within 12 to 24 UK business hours.

Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile

  • Product Code:GMD12576
  • Publication Date:July 2009
  • Publisher:Global Markets Direct
  • Product Type: Report
  • Pages:13
Change currency
Add to my wish list > Ask a question about this product > Call now +44 20 8816 8548
Request sample

Request a sample for Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha

Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile

Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Neurocrine Biosciences, Inc. (Neurocrine) is a biopharmaceutical company, engaged in the discovery, development and commercialization of innovative pharmaceutical products for the treatment of neurological and endocrine-related diseases and disorders. The company has developed many of its product candidates targeted at world's largest pharmaceutical markets such as endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders.

Global Market Direct's Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

  • Provides key company information for business intelligence needs
  • Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

  • A quick ""one-stop-shop"" to understand the company.
  • Support sales activities by understanding your customers' businesses.
  • Qualify prospective partners and suppliers.
  • Understand and respond to your competitors' business structure, strategy and prospects through.
  • Understanding the key deals which have shaped the company.
Table Of Contents Table Of Contents 2 List of Tables 2 List of Figures 2 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 6 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deal Details 8 Asset Purchase 8 Neurocrine Acquires Indiplon Royalty Stream From Wyeth 8 Partnerships 9 Neurocrine Biosciences Signs an Agreement With Dainippon Sumitomo Pharma 9 Neurocrine Biosciences and Pfizer Terminate Collaboration Agreement 10 Neurocrine Biosciences Entered into Licensing Agreement With Almirall Prodesfarma 11 Key Competitors 12 Key Employees 12 Locations And Subsidiaries 12 Head Office 12 Appendix 13 Methodology 13 About Global Markets Direct 13 Contact Us 13 Disclaimer 13 List of Tables Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Neurocrine Biosciences, Inc., Deals By Sector, 2004 to YTD 2009 6 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7 Neurocrine Acquires Indiplon Royalty Stream From Wyeth 8 Neurocrine Biosciences Signs an Agreement With Dainippon Sumitomo Pharma 9 Neurocrine Biosciences and Pfizer Terminate Collaboration Agreement 10 Neurocrine Biosciences Entered into Licensing Agreement With Almirall Prodesfarma 11 Neurocrine Biosciences, Inc., Key Employees 12 List of Figures Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 4 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 6
Ask a question about this product

Ask a question about Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha